ADTX vs BDX · rev $134.0K vs P/E 34, rev $21.84B
Aditxt Inc. (ADTX) versus Becton Dickinson and Company (BDX) — a side-by-side from cached financials, not a winner call.
Aditxt Inc. (ADTX) is a biotechnology company listed on NASDAQ.
Becton Dickinson and Company (BDX) is a medical instruments & supplies company listed on US.
Latest reported ADTX revenue for 2024-12-31 was $134.0K. Net income was -$35.0M. Revenue was down 79.2% from 2023-12-31 to 2024-12-31. ADTX currently screens at market cap $3.6K.
Latest reported BDX revenue for 2025-09-30 was $21.84B. Net income was $1.68B. Revenue was up 8.2% from 2024-09-30 to 2025-09-30. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
ADTX currently screens at market cap $3.6K. BDX currently screens at market cap $50.30B and trailing P/E 33.9.
Not investment advice. Open the ADTX and BDX stock pages for the full models.
Not investment advice.